Changeflow GovPing Pharma & Drug Safety Arrow International Removes Dialysis Catheter K...
Urgent Enforcement Amended Final

Arrow International Removes Dialysis Catheter Kits Containing Merit Medical Sheath Introducer

Favicon for www.fda.gov FDA MedWatch Safety Alerts
Filed
Detected
Email

Summary

Arrow International has issued an early alert recommending removal of dialysis catheter kits containing Merit Medical 16F Dual-Valved Splittable Sheath Introducers from use or sale due to a design defect where the sheath introducer may not split as intended. The defect may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, or loss of vessel for future vascular access. As of February 23, Merit Medical has reported two serious injuries and no deaths associated with this issue. Affected products include Arrow Edge Hemodialysis Catheterization Product, Arrow-Clark VectorFlow Antegrade and Retrograde Chronic Hemodialysis Catheters, Cannon II Plus Chronic Hemodialysis Catheter, and NextStep Antegrade and Retrograde Chronic Hemodialysis Catheters.

“Do not use Merit Medical 16F Dual-Valved Splittable Sheath Introducers in the Arrow International kits and sets.”

FDA , verbatim from source
Published by FDA on fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors FDA MedWatch Safety Alerts for new pharma & drug safety regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 16 changes logged to date.

What changed

Arrow International has initiated an urgent medical device recall for dialysis catheter kits containing Merit Medical 16F Dual-Valved Splittable Sheath Introducers. The sheath introducer component may fail to split as intended, posing risks including hemorrhage, foreign body retention, procedure delays, embolization/thrombosis, and loss of vessel access. Six Arrow hemodialysis catheter product lines are affected: Arrow Edge, Arrow-Clark VectorFlow (antegrade and retrograde), Cannon II Plus, and NextStep (antegrade and retrograde). Healthcare providers should immediately stop using affected products, quarantine stock, and initiate returns through Arrow International or Teleflex Customer Service at 1-866-396-2111 or Recalls@teleflex.com.

Affected healthcare facilities and distributors must identify the specific lots in their inventory, remove affected products from service, and coordinate return with Arrow International. The FDA is actively reviewing this device issue and will update the early alert web page as new information becomes available. This recall originates from Merit Medical's prior dialysis catheter recall of the same 16F sheath introducer component, with injury reports dating to February 2026.

What to do next

  1. Do not use Merit Medical 16F Dual-Valved Splittable Sheath Introducers in the Arrow International kits and sets
  2. Immediately stop use and distribution of the affected kits and sets
  3. Return affected kits and sets to Arrow International

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.


CDRH is issuing this Early Alert **to notify the public of a potentially high-risk device issue.* The FDA will keep the public informed and update this web page as significant new information becomes available.*

Affected Product

The FDA is aware that Arrow International has issued a letter to affected customers recommending dialysis catheter kits containing Merit Medical 16F Dual-Valved Splittable Sheath Introducers be removed from where they are used or sold.

Affected products:

  • Arrow Edge Hemodialysis Catheterization Product
  • Arrow-Clark VectorFlow Antegrade Chronic Hemodialysis Catheter
  • Arrow-Clark VectorFlow Retrograde Chronic Hemodialysis Catheter
  • Cannon II Plus Chronic Hemodialysis Catheter
  • NextStep Antegrade Chronic Hemodialysis Catheter
  • NextStep Retrograde Chronic Hemodialysis Catheter Full list of affected product lots

What to Do

Do not use Merit Medical 16F Dual-Valved Splittable Sheath Introducers in the Arrow International kits and sets.

In April, Arrow International sent all affected customers a letter recommending the following actions:

  • Immediately stop use and distribution of the affected kits and sets.
  • Return affected kits and sets to Arrow International. Check this web page for updates. The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available.

Reason for Alert

Arrow International initiated an urgent Medical Device Recall notification for kits that contain hemodialysis catheters affected by Merit Medical’s Dialysis Catheter Recall: Merit Medical Removes 16F Dual-Valved Splittable Sheath Introducer.

Merit Medical is recalling the Merit 16F Dual-Valved Splittable Sheath Introducer due to a design defect where the sheath introducer may not split as intended. This sheath introducer is used in several impacted Arrow Hemodialysis Kits and Sets. Failure of the sheath introducer to split as intended may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access.

As of February 23, Merit Medical has reported two serious injuries and no deaths associated with this issue. As of April 21, Arrow International has not reported any additional patient injuries or deaths.

Device Use

The 16F Dual-Valved Splittable Sheath Introducer is a component used in several Arrow Hemodialysis kits and sets and is packaged within the sterile barrier of the finished goods. The introducer is used for the delivery of the catheter into the vascular system.

Contact Information

Customers in the U.S. with adverse reactions, quality problems, or questions about this recall should contact Teleflex Customer Service at Recalls@teleflex.com or 1-866-396-2111.

Additional FDA Resources

Unique Device Identifier (UDI)

The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

  • ## Content current as of:

04/24/2026

  • Regulated Product(s)

    • Medical Devices

Get daily alerts for FDA MedWatch Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
April 24th, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers Medical device makers Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall Product withdrawal Adverse event monitoring
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA MedWatch Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!